Cholesterol Monitoring System

Contents 1 2

Introduction to Cholesterol Mission® Cholesterol Monitoring System

3 4

Competitor Analysis

5

Product Catalog

6 CONFIDENTIAL For Distributor Reference Only

Target Markets

Sales Support Materials 2

1. Introduction to Cholesterol Cholesterol is grouped into the following types: High Density Lipoprotein（HDL） Low Density Lipoprotein （LDL） Triglycerides (TRIG) Total Cholesterol (CHOL)

CONFIDENTIAL For Distributor Reference Only

3

1. Introduction to Cholesterol Understanding the Risk of High Cholesterol High cholesterol can cause atherosclerosis, a dangerous accumulation of cholesterol and other deposits on the walls of your arteries. The build up of plaque in the arteries can cause complications, such as chest pain, heart attacks, and strokes. Some risk factors that can cause high cholesterol include:

Symptoms of high cholesterol may not be obvious. High cholesterol complications are usually not immediate. The damage grows each year.

• Smoking

• Diabetes

• Obseity

• A Family History of High Cholesterol

• Lack of exercise • High blood pressure

CONFIDENTIAL For Distributor Reference Only

4

• Poor Diet

1. Introduction to Cholesterol

Worldwide Prevalence

High Cholesterol is a major risk factor for heart Disease, or Cardiovascular Disease (CVD).

Prevalence of Elevated Total Cholesterol

% calculated by World Health Organization

60%

High Total Cholesterol is a large risk factor for heart disease and stroke both in the developed and developing worlds.

54% 48%

50% 40%

According to the World Health Organization (WHO), it is estimated that 17 million people around the world die of CVD each year. This is over 29% of all deaths worldwide.

29%

30%

23%

20% 10%

The prevalence of high Total Cholesterol is highest in Europe (54%), followed by the Americas (48%), Africa (23%), and South East Asia (29%).

0% Europe

Americas

Africa

South East Asia

Regions

CONFIDENTIAL For Distributor Reference Only

5

1. Introduction to Cholesterol In the U.S.

USA Prevalence

CVD is the # 1 cause of death. % of Americans Adults with LDL cholesterol of 3.4 mmol/L (130 mg/dL) 50% 43%

45% 40% Percentage

35%

32%

34%

34% 29%

30%

30%

25% 20% 15% 10% 5% 0% non- Hispanic Hispanic nonnonnonHispanic Hispanic Hispanic Hispanic men women white white black black men women women men Ethnicity

CONFIDENTIAL For Distributor Reference Only

In adults, Total Cholesterol levels of 240 mg/dL (6.2 mmol/L) or higher are considered high risk. Levels from 200 to 239 mg/dL (5.2 – 6.2 mmol/L) are considered borderline-high risk. An estimated 101 million adults in the US have Total Cholesterol values of 200 mg/dL (5.2 mmol/L) or higher, and of these about 35.7 million American adults have levels of 240 mg/dL (6.2 mmol/L) or above. Among Americans age 20 and older, the following have a LDL cholesterol of 130 mg/dL (3.4 mmol/L) or higher: 32% of non-Hispanic white men 34% non-Hispanic white women 34% of non-Hispanic black men 29% of non-Hispanic black women 43% of Hispanic men 30% of Hispanic women

6

1. Introduction to Cholesterol • POCT Market Size The Point Of Care Diagnostics market was worth $13.7 billion in 2010 and rose by 3% since 2009.

• Global Market for Cholesterol

Market Opportunity

Based on the market research by Global Industry Analysts, the global market for cholesterol and other cardiovascular testing is forecasted to surpass 2.3 billion units by the year 2015.

• Key Driver The key factors driving the market growth include an aging population, increasing incidence of cardiovascular diseases, and a growing awareness among people about the significance of reducing their unhealthy cholesterol levels.

• Demand for Cardiovascular Testing Excluding the glucose market, the POC market rose by 7% in 2010, driven by a demand for cardiovascular testing products, including cholesterol monitoring systems. CONFIDENTIAL For Distributor Reference Only

7

1. Introduction to Cholesterol Overview of Cholesterol Tests There are multiple types of cholesterol circulating the blood. Cholesterol levels are measured and diagnosed with a simple blood test, often called a Lipid Panel. The Lipid Panel test provides results for four different types of lipids: Total Cholesterol (CHOL) High-Density Lipoprotein (HDL) Low-Density Lipoprotein (LDL) Triglycerides (TRIG)

CONFIDENTIAL For Distributor Reference Only

8

1. Introduction to Cholesterol Blood Cholesterol Levels Cholesterol

Desirable

Borderline High

High Risk

Total Cholesterol (CHOL)

< 200 mg/dL (5.2 mmol/L)

200 - 240 mg/dL (5.2 – 6.2 mmol/L)

> 240 mg/dL (6.2 mmol/L)

60 - 50 mg/dL (1.5 - 1.3 mmol/L) for women 60 - 40 mg/dL (1.5 - 1.0 mmol/L) for men

< 50 mg/dL (1.3 mmol/L) for women < 40mg/dL (1.0 mmol/L) for men

High Density Cholesterol (HDL)

> 60 mg/dL (1.5 mmol/L)

Low Density Cholesterol (LDL)

< 130 mg/dL (3.4 mmol/L)

130 - 160 mg/dL (3.4 - 4.1 mmol/L)

> 160 mg/dL (4.1 mmol/L)

Triglycerides (TRIG)*

< 150 mg/dL (1.7 mmol/L)

150 - 200 mg/dL (1.7 - 2.3 mmol/L)

> 200 mg/dL (2.3 mmol/L)

*These are based on fasting plasma triglyceride levels from the American Heart Association. CONFIDENTIAL For Distributor Reference Only

9

1. Introduction to Cholesterol Total Cholesterol CHOL is the Total Cholesterol measurement of HDL cholesterol, LDL cholesterol, and other lipid components. The American Heart Association states that the desirable level of CHOL is less than 5.2 mmol/L (200 mg/dL), which puts the patient at a lower risk for coronary heart disease.

Total Cholesterol Level

Category

< 200 mg/dL (5.2 mmol/L)

Desirable level that puts you at a lower risk for coronary heart disease. A cholesterol level of 5.2 mmol/L (200 mg/dL) or higher raises the patients risk.

200 – 240 mg/dL (5.2 – 6.2 mmol/L)

Borderline high

> 240 mg/dL (6.2 mmol/L)

High blood cholesterol. A person with this level has more than twice the risk of coronary heart disease as someone whose cholesterol is below 5.2 mmol/L (200 mg/dL).

A CHOL level of 5.2 mmol/L (200 mg/dL) or higher raises the patient’s risk. CONFIDENTIAL For Distributor Reference Only

10

1. Introduction to Cholesterol HDL Cholesterol HDL Cholesterol is sometimes referred to as the “good” cholesterol because it helps carry the LDL cholesterol away from tissues and to the liver for disposal. Low HDL level puts you at risk for heart disease. For the average man, the normal HDL level range is from 40 – 50 mg/dL (1.0 – 1.3 mmol/L). For the average woman, the normal range is 50 – 60 mg/dL (1.3 – 1.6 mmol/L). Activities, such as smoking, being overweight, and being sedentary can lower a person’s HDL level. To raise your HDL level, avoid tobacco, maintain a healthy weight, and get at least 3060 minutes of physical activity each day. CONFIDENTIAL For Distributor Reference Only

11

HDL Cholesterol Level

Category

> 60 mg/dL (1.5 mmol/L)

High HDL cholesterol. An HDL of > 60 mg/dL (1.5 mmol/L) is considered protective against heart disease.

Men: 60 – 40 mg/dL (1.5 – 1.0 mmol/L); Women: 60-50 mg/dL (1.5-1.3 mmol/L) Men: < 40 mg/dL (1.0 mmol/L ); Women:< 50 mg/dL (1.3 mmol/L)

Borderline high

Low HDL cholesterol. A major risk factor for heart disease.

1. Introduction to Cholesterol LDL Cholesterol LDL Cholesterol is also known as the “bad” cholesterol. Too much LDL in the blood will cause a buildup of plaque in your arteries, which can reduce blood flow. An even greater danger than slow blood flow from a blockage is a sudden rupture of the surface of the plaque. A blood clot can form on the ruptured area, causing a heart attack. The lower your LDL level, the lower your risk of heart attack and stroke. For people at high risk of heart disease or with known heart disease, LDL of less than 5.6 mmol/L (100 mg/dL) is advised. CONFIDENTIAL For Distributor Reference Only

12

LDL Cholesterol Level

Category

< 100 mg/dL (2.6 mmol/L)

Optimal

100 – 130 mg/dL (2.6 – 3.4 mmol/L)

Near or above optimal

130 – 160 mg/dL (3.4 – 4.1 mmol/L)

Borderline high

160 to 189 mg/dL (4.1 – 4.9 mmol/L)

High

> 190 mg/dL (4.9 mmol/L)

Very high

1. Introduction to Cholesterol Triglycerides Triglycerides are a type of fat in the blood that are used for energy. Triglyceride levels are strongly influenced by diet. It is recommended that triglyceride levels be tested after fasting for 8-12 hours. When a person eats more calories than what they can burn, they may have high triglycerides. High levels are also seen in overweight people, in those who eat too many sweets or drink too much alcohol, and in people with diabetes who have elevated blood sugar levels. Many people have high triglyceride levels due to being overweight, little or no physical activity, smoking, consuming excess alcohol and/or eating a diet very high in carbohydrates . CONFIDENTIAL For Distributor Reference Only

13

Triglycerides Level

Category

< 150 mg/dL (1.7 mmol/L)

Normal

150 – 200 mg/dL (1.7 – 2.3 mmol/L)

Borderline high

200 – 500 mg/dL (2.3 – 5.7 mmol/L)

High

> 500 mg/dL (5.7 mmol/L)

Very high

* These are based on fasting plasma triglyceride levels from the American Heart Association.

2. Mission® Cholesterol Monitoring System

1.

Efficient

Reliable

Convenient

Complete Lipid Panel testing with 3-1 or Individual Test Device

2.

Results in as little as 45 seconds

1.

Can test whole blood, serum, or plasma

2.

Tests for CHOL, HDL, and TRIG, and calculates LDL, CHOL/HDL ratio, and Cardiac Risk Assessment

1.

Large LCD display for easy reading

2.

Color coded and engraved devices for convenient testing

CONFIDENTIAL For Distributor Reference Only

14

Reality Efficient

Convenient Reliable

Innovation

Coronary Heart Disease (CHD) Analysis

 Two Evaluation Methods Are Recommended for CHD Analysis: PRO

(Procam method), popular in Europe, for men between the ages of 35-65. FRA (Framingham heart study), popular in the US, for both men and women between the ages of 30-79. 

The Mission® Cholesterol Monitoring System offers both the PRO and FRA evaluation methods.



Choose either PRO or FRA before beginning the CHD risk assessment.

15

Innovation

Coronary Heart Disease (CHD) Analysis

The factors that increase a person’s risk for CHD included in the PROCAM calculation are age, LDL cholesterol, HDL cholesterol, Triglycerides, Systolic Blood Pressure, Diabetes Mellitus, and if Myocardial Infarction runs in the person’s family history.

The factors that increase a person’s risk for CHD included in the Framingham calculation are age, Total Cholesterol, HDL cholesterol, Systolic Blood Pressure,whether the person has had treatment for hypertension, and if they smoke cigarettes.

16

Innovation

Coronary Heart Disease (CHD) Analysis

According to National Cholesterol Education Program (NCEP), ATP 3, 2001, 10 Year risk is defined in three levels:

10-Year risk ≤10%

Low Risk

10%< 10-Year risk ≤20%

Medium Risk

10-Year risk >20%

High Risk

2. Mission® Cholesterol Monitoring System Specification Precision

CHOL: 100-500 mg/dL (2.6 – 12.9 mmol/L); ≤ 5.0%, HDL: 30-100 mg/dL (0.8 – 2.6 mmol/L); ≤ 5.0% TRIG: 100-650 mg/dL (1.1 – 7.3 mmol/L); ≤ 5.0% Specimen Volume: 10 µL for CHOL, HDL, or TRIG Individual Devices 35 µL for 3-in-1 Lipid Panel Test Device Specimen Type: Whole blood, serum or plasma

Test Specimen

Operating Conditions: 15-40 ˚C (55-113ºF); ≤ 90% RH Meter Storage: 0-50 ˚C (32-122ºF); ≤ 90% RH Device Storage: 2-30 ˚C (35.6-86ºF); ≤ 90%

Conditions Hematocrit Range

0~55%

PC Interface

USB port

Power Source Storage Memory CONFIDENTIAL For Distributor Reference Only

18

4 AAA Batteries (>1,000 tests)

200 results with date/time

2. Mission® Cholesterol Monitoring System Components 1. USB Port 2. Liquid Crystal Display (LCD) 3. Code Chip 4. Right Arrow ► Button 5. On/Off Button 6. Left Arrow ◄ Button 7. Device Channel 8. Test Device Holder 9. Code Chip Slot 10. Battery Cover

1. Battery Symbol 2. Beep 3. Date/Time 4. Test Number 5. Blood Drop Symbol 6. Test Results / Code Number 7. Device Symbol 8. Memory 9. Code Symbol 10. Measurement Units 11. Test Result 12. Blood Pressure Unit (mmHg) 13. Patient Information Symbol CONFIDENTIAL For Distributor Reference Only

19

2. Mission® Cholesterol Monitoring System Testing Procedures 1. Meter Setup A. Install Batteries B. Setup System C. Insert the Code Chip into the Meter

2. Turn on the meter and collect blood specimen

3. Read the Results

CONFIDENTIAL For Distributor Reference Only

20

2. Mission® Cholesterol Monitoring System Selling Points Accurate

Wide measurement range of 100 – 500 mg/dL (2.6 – 12.9 mmol/L) for CHOL, 15 – 100 mg/dL (0.4 – 2.6 mmol/L) for HDL and 45 – 650 mg/dL (0.5 – 7.3 mmol/L) for TRIG

Simple

Requires only 10 µL of specimen for Individual Test Devices and 35 µL for 3-in-1 Lipid Panel Test Devices

Flexible

View results in mg/dL or mmol/L

Compact

Handheld design makes it ideal for use in physician offices, Homes, hospitals, or pharmacies

Data transfer

Via USB port for simple record keeping

Quick Quick Results Results

Provides Lipid Panel results, including CHOL, TRIG, HDL, and calculated LDL, CHOL/HDL, and CHD Analysis in as little as 45 seconds

CONFIDENTIAL For Distributor Reference Only

21

3. Target Markets for Cholesterol Testing

• Physician Offices • Homes • Urgent Care Centers • Community Health Centers • Hospitals • Public and Private Labs • Pharmacies • Pharmaceutical Distributors

CONFIDENTIAL For Distributor Reference Only

22

3. Target Markets for Cholesterol Testing Cholesterol Control Medicines

In the top 10 medicine category sales from 2003-2005, cholesterol lowing drugs ranked #1 with a total sales amount of $31.6 billion in 2005, $30.2 billion in 2004, and $26.1billion in 2003.

CONFIDENTIAL For Distributor Reference Only

Top 500 prescription drugs in 2004 by pharmalive.com, Lipitor ranked #1 with $11 million sales, and Zocor ranked 2nd with $5 million.

23

Among the top 10 prescription drugs sold by pharmaceutical and biotechnology companies in 2011, two of them are cholesterol lowing drugs including Lipitor (Pfizer) and Crestor (AstraZeneca).

3. Target Markets for Cholesterol Testing Partner with Pharmaceutical Company 1. Pfizer Pharmaceuticals (1849, USA) Lipitor, also called Atorvastatin Calcium Tablets, is the world's best-selling cardiovascular drug, which sold over $10 billion in 2010.

2. Merck & Co. Inc. (1891 USA/German) Vytorin Zocor, also named simvastatin, is the 2nd largest selling cholesterol lowering drug in the world. Zocor posted sales of $6.0 billion in 2010.

3. Bristol-Myers Squibb (1858, USA) PRAVACHOL® (pravastatin sodium) is one of the class of lipid-lowering compounds, which reduces cholesterol biosynthesis. In 2004, its sales amount was $ 2.6 billion, ranking it 17th in the 2004 top 500 prescription drugs.

CONFIDENTIAL For Distributor Reference Only

24

4. Competitor Analysis – Mission® vs Other Optical Cholesterol Meters Manufacturer

Parameter

Specimen

Individual or Multi Strips

Specimen Volume

Individual* and 3-in-1

CHOL, HDL, TRIG, Calculated LDL and CHOL/HDL

FCWB, VB, plasma, and serum

Competitor A Europe

CHOL; GLU

FCWB, or VB w/EDTA

Competitor B Europe

CHOL, TRIG; GLU; Lactate

FCWB

Individual

Competitor C Europe

CHOL, TRIG; GLU

FCWB, or VB w/EDTA

Individual

Competitor D USA

CHOL, HDL, TRIG, Calculated LDL; GLU; KET

FCWB or VB w/ EDTA or heparin

Mission® (ACON – USA)

Individual

Individual

Time for Result

Memory

As little as 45s

200 tests

CHOL

HDL

TRIG

10 µL for Individual Tests*; 35 µL for 3-in-1 Lipid Panel

100-500 mg/dL (2.6-12.9 mmol/L)

15-100 mg/dL (0.4-2.6 mmol/L)

45-650 mg/dL (0.5-7.3 mmol/L)

15-40µL

150-300 mg/dL 3.8-7.8 mmol/L

N/A

N/A

15-40µL

150-300 mg/dL 3.8-7.8 mmol/L

N/A

70-600 mg/dL (0.8-6.9 mmol/L)

180s

100 results

15-40µL

150-300 mg/dL (3.8-7.8 mmol/L)

N/A

70-600 mg/dL (0.8-7.0 mmol/L)

180s

120 results

15µL

100-400 mg/dL (2.6-10.6 mmol/L)

25-85 mg/dL (0.6-2.2 mmol/L)

50-500 mg/dL (1.3-13 mmol/L)

< 60s

30

FCWB: Fingertip Capillary Whole Blood * Coming soon CONFIDENTIAL For Distributor Reference Only

Measurement Range

25

180s

65 results

4. Competitor Analysis – Mission® vs Other Optical Cholesterol Meters Manufacturer

Parameter

Specimen

Mission® (ACON – USA)

CHOL, HDL, TRIG, Calculated LDL and CHOL/HDL

Competitor A USA

CHOL, HDL, TRIG, Calculated LDL; GLU; KET; Creatinine

FCWB, or VB w/ EDTA or heparin

Competitor B Asia

CHOL, HDL, TRIG, Calculated LDL; GLU

FCWB, VB, plasma, and serum

FCWB, VB, plasma, and serum

Competitor C Europe

CHOL, TRIG, GLU

FCWB

Competitor D Asia

Lipid Panel: CHOL, HDL, TRIG, Calculated LDL, LDL/HDL, non-HDL, GLU

FCWB, VB, plasma, and serum

* Coming soon CONFIDENTIAL For Distributor Reference Only

Individual or Multi Parameter Strips

Specimen Volume

Individual* and 3-in-1

10 µL for Individual Tests; 35 µL for 3-in-1 Lipid Panel

Individual and 3-in-1

15µL; 35-40µL for 3-in-1; 30 µL for 21

Measurement Range

As little as 45s

200 tests

HDL

TRIG

2.6-12.9 mmol/L (100-500 mg/dL)

0.4-2.6 mmol/L (15-100 mg/dL)

0.5-7.3 mmol/L (45-650 mg/dL)

0.6-2.2 mmol/L (25-85 mg/dL)

0.6-5.8 mmol/L( 50-500 mg/dL)

2.1-15.5 mmol/L( 80-600 mg/dL)

0.3-0.9 mmol/L( 25-80 mg/dL)

≤ 120s

200

30s

500 results

≤ 180s

500

2.6-10.4 mmol/L (100-400 mg/dL)

5 µL

Individual

10 µL

3.3-10.2 mmol/L (130-400 mg/dL)

N/A

0.565.65 mmol/L (50-500 mg/dL)

Individual & Multi

10 µL for single; 35 µL for 3-in1

2.5911.64 mmol/L (100-400 mg/dL)

0.65-2.5 mmol/L (25-95 mg/dL)

.57-7.4 mmol/L (50-650 mg/dL)

26

Memory

CHOL

2.6-10.6 mmol/L (100-400 mg/dL)

Individual

Time for Result

60 - 120s

240 results

4. Competitor Analysis – Mission® vs Biosensor Cholesterol Meters Manufacturer

Parameter

Specimen *

Specimen Volume

Measurement Range CHOL

HDL

TRIG

Time for Result

Memory

CHOL, HDL, TRIG, Calculated LDL and CHOL/HDL

FCWB, VB, plasma, and serum

10 µL for Individual Tests*; 35 µL for 3-in-1 Lipid Panel

2.6-12.9 mmol/L (100-500 mg/dL)

0.4-2.6 mmol/L (15-100 mg/dL)

0.5-7.3 mmol/L (45-650 mg/dL)

As little as 45s

200 tests

Competitor A USA

CHOL; GLU

FCWB

10 µL

3.37-9.07 mmol/L (130350 mg/dL)

N/A

N/A

30s

50 results

Competitor B Asia

CHOL; GLU; UA

FCWB

10 µL

2.59-10.35 mmol/L (100400 mg/dL)

N/A

N/A

30-40s

50 results

Competitor C Asia

CHOL; GLU; UA

FCWB

≥ 15 µL

2.59-10.35 mmol/L (100400 mg/dL)

N/A

N/A

150s

300 results

Competitor D Asia

CHOL; GLU; UA

FCWB

≥ 15 µL

2.59-10.35 mmol/L (100400 mg/dL)

N/A

N/A

150s

300 results

Competitor E Europe

CHOL; GLU; UA

FCWB

10 µL

2.59-10.35 mmol/L (100400 mg/dL)

N/A

N/A

15s

50 results

Competitor F Asia

CHOL; GLU

FCWB

15 µL

3.9 – 9.1 mmol/L (150350 mg/dL)

N/A

N/A

90s

300 results

Mission® (ACON – USA)

* Coming soon

CONFIDENTIAL For Distributor Reference Only

27

4. Competitor Analysis – Mission® vs Small Desktop Chemistry Analyzers Manufacturer

Mission® (ACON – USA)

Parameter

Specimen

Measurement Range

Specimen Volume

Time for Result

Test Storage

Memory

As little as 45s

0-50℃ (32-122°F)

200 tests

CHOL

HDL

TRIG

10 µL for Individual Tests*; 35 µL for 3in-1 panel

2.6-12.9 mmol/L (100-500 mg/dL)

0.4-2.6 mmol/L (15-100 mg/dL)

0.5-7.3 mmol/L (45-650 mg/dL)

30 µL

2.6- 12.9 mmol/L (100-500 mg/dL)

0.3-2.6 mmol/L (10-100 mg/dL)

0.8-7.0 mmol/L (70-600 mg/dL)

0.4-2.6 mmol/L (15-100 mg/dL)

0.5-7.6 mmol/L (45-650 mg/dL)

5 mins

2-8 ℃

N/A

CHOL, HDL, TRIG, Calculated LDL and CHOL/HDL

FCWB, VB, plasma, and serum

Competitor A - Europe

CHOL, HDL, TRIG, and other 13 parameters

FCWB, VB, plasma, and serum

Competitor B - USA

CHOL, HDL,TRIG, Calculated LDL, GLU, KET

FCWB, VB, plasma, and serum

35-50 µL

2.59 – 12.9 mmol/L (100-500 mg/dL);

Competitor C - Europe

Lipid (Not launched yet), CRP, HbA1C, ACR

FCWB, VB, plasma, and serum

N/A

N/A

N/A

N/A

N/A

2-8 ℃

N/A

Competitor D - USA

Lipid Panel: CHOL, HDL, TRIG, Calculated LDL, Calculated VLDL, CHOL/HDL ratio

FCWB, VB, plasma, and serum

100-120 µL

0.52-13.5 mmol/L (20-520 mg/dL)

0.39-2.6 mmol/L (15-100 mg/dL)

0.23-5.7 mmol/L(20500 mg/dL)

12 mins

2-8 ℃

N/A

* Coming soon

* FCWB: Fingertip Capillary Whole Blood

28

120-180s

2-30 ℃ with some requiring 2-8 ℃

60 results

5. Product Catalog Mission® Cholesterol Monitoring System Product Name

Catalog No.

Mission® Cholesterol Meter

C111-2021√

Mission® 3-in-1 Lipid Panel Test Devices

C131-2041√

Mission® CHOL Total Cholesterol Test Devices*

C131-2011√

Mission® HDL High Density Test Devices*

C131-2031√

Mission® Mission® Mission® Mission® Mission® Mission® Mission® Mission® Mission®

C131-2021√ C121-2021√ C121-2011√ C121-3081√ C121-3041√ C121-3051√ C121-3061√ C121-3011√ Contact us

TRIG Triglyceride Test Devices* CTRL Control Test Devices Control Solution Capillary Transfer Tubes Lancets Lancing Devices Safety Lancets I Adaptor Kit External Printer

Components 1 Meter 1 Carrying Case 1 Manual 4 Batteries 2 Control Devices (2/canister) 1 Control Device Insert Package 1: Package 2*: 5 Test Devices (Individual Pouches) 20 Test Devices (10/canister) 5 Capillary Transfer Tubes or 20 Capillary Transfer Tubes1 1 Code Chip Code Chip 1 Package Insert 1 Package Insert 2 Control Devices (2/canister) 1 Package Insert 2 Normal Level Control Solutions 2 High Level Control Solutions 50 or 100 Capillary Transfer Tubes (10 μL and 35 μL) 100 Lancets 1 Lancing Device 1 Lancing Device Insert 20 Lancets/Kit (21G/2.8 mm) 1 Power Adaptor 1 External Printer

1 Quick Reference Guide 1 Warranty Card 5 Safety Lancets (21G/2.8 mm) Package 3: 25 Test Devices (Individual Pouches) or 25 Capillary Transfer Tubes 1 Code Chip 1 Package Insert 1 Control Solution Insert

* Coming soon

29

6. Sales Support Materials

Mission® Cholesterol Monitoring System Sell Sheet – Distributor Mission® Cholesterol Monitoring System Sell Sheet – OTC Mission® Cholesterol Monitoring Introduction Presentation Mission® Cholesterol Monitoring System Launch Packet Mission® Cholesterol Monitoring System Report – Evaluation Report Mission® Cholesterol Monitoring System Report – Clinical Comparison Report Mission® Educational Brochure – Controlling Your Cholesterol Mission® Cholesterol Monitoring System Customized Posters to display at local trade shows (upon request) 9. Product Catalog and Price List (upon request) 10. Website information (http://www.aconlabs.com/) 11. Custom OEM options for large volumes …and more! (inquire for details)

1. 2. 3. 4. 5. 6. 7. 8.

CONFIDENTIAL For Distributor Reference Only

30

Take advantage of this opportunity to penetrate the worldwide market and become the market leader with the

Cholesterol Monitoring System Contact us for further details!

CONFIDENTIAL For Distributor Reference Only

31